Drug companies should agree to “pay or play” in the urgent race to develop new antibiotics to tackle a gl ...

Drug companies should agree to “pay or play” in the urgent race to develop new antibiotics to tackle a global threat of antimicrobial resistance (AMR), according to a British government-commissioned r ...